The SOT Continuing Education Committee is pleased to offer a wide-range of Continuing Education (CE) courses on Sunday, March 10, at the SOT Annual Meeting in Baltimore, Maryland.
This 2018 CE course on lead optimization provided an extensive overview of the strategies and approaches leading from drug target selection to lead identification, optimization, and selection of clinical candidates for first-in-human studies.
Recent years have seen an increasing surge in the development of novel biotherapeutics. Preclinical safety evaluation plays a crucial role in drug development and the highly diverse modalities and complexity of biotherapeutics poses several development challenges.
The trend of shifting toxicology testing from animal testing to alternative methods has penetrated all subfields in toxicology. A 2018 Continue Education course focused on discussion of the progress, current status, and needs of alternative toxicology testing for consumer products.
This sunrise Continuing Education course was comprised of two lectures, one being on the structure and function of CRISPR and second on its applications in toxicology. Both talks were stupendously organized and informative.